Halozyme Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	133.82	115.85	118.37	234.2	118.72
Short-Term Investments	9	480.22	217.63	128.6	622.2
Cash & Short-Term Investments	142.82	596.07	336	362.79	740.92
Cash Growth	-76.04%	77.40%	-7.38%	-51.03%	101.33%
Accounts Receivable	441.27	308.46	234.21	231.07	90.98
Inventory	176.48	141.86	127.6	100.12	53.91
Other Current Assets	64.64	38.95	48.61	45.02	40.48
Total Current Assets	825.21	1,085	746.42	739.01	926.29
Net Property, Plant & Equipment	82.14	75.04	74.94	75.57	8.79
Other Intangible Assets	981.47	401.83	472.88	546.65	-
Goodwill	580.36	416.82	416.82	409.05	-
Other Long-Term Assets	56.15	84.45	22.2	71.23	169.35
Total Assets	2,525	2,063	1,733	1,842	1,104
Accounts Payable	20.9	10.25	11.82	17.69	1.54
Accrued Expenses	156.19	128.85	100.68	99.76	24.44
Current Portion of Long-Term Debt	-	-	-	13.33	89.42
Unearned Revenue	-	-	-	-	1.75
Total Current Liabilities	177.09	139.1	112.49	130.79	117.15
Long-Term Debt	2,143	1,506	1,499	1,493	787.26
Other Long-Term Liabilities	156.79	54.76	37.72	48.16	3.07
Total Long-Term Liabilities	2,299	1,561	1,537	1,541	790.33
Total Liabilities	2,477	1,700	1,649	1,672	907.48
Common Stock	0.12	0.12	0.13	0.14	0.14
Additional Paid-in Capital	12	-	2.41	27.37	256.35
Accumulated Other Comprehensive Income	-18.09	3.83	-9.28	-0.92	-0.62
Retained Earnings	54.79	359.87	90.55	143.22	-58.91
Shareholders' Equity	48.81	363.82	83.81	169.8	196.95
Total Liabilities & Equity	2,525	2,063	1,733	1,842	1,104
Total Debt	2,143	1,506	1,499	1,506	876.67
Net Cash (Debt)	-2,000	-909.72	-1,163	-1,143	-135.75
Net Cash Per Share	-16.14	-7.03	-8.67	-8.13	-0.93
Book Value	48.81	363.82	83.81	169.8	196.95
Book Value Per Share	0.39	2.81	0.62	1.21	1.34
Tangible Book Value	-1,513	-454.83	-805.89	-785.9	196.95
Tangible Book Value Per Share	-12.21	-3.51	-6.01	-5.59	1.34

Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q